Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
39,757,863
-
Share change
-
+3,736,948
-
Total reported value
-
$952,008,187
-
Price per share
-
$23.95
-
Number of holders
-
76
-
Value change
-
+$87,935,702
-
Number of buys
-
50
-
Number of sells
-
22
Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q2 2021
As of 30 Jun 2021 Kronos Bio, Inc. - Common Stock (KRON) had 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,757,863 shares of stock of the company.
Largest 10 holders included Omega Fund Management, LLC, Capital World Investors, VANGUARD GROUP INC, BlackRock Inc., Capital Research Global Investors, Vida Ventures Advisors, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JPMORGAN CHASE & CO.
This table shows 76 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.